The Science-Backed GHK-Cu Benefits 1
Reduced glutathione (GSH) is a tripeptide composed of the amino acids glutamate, cysteine, and glycine
Produced in the liver & kidneys, it plays an essential role in energy production
Demonstrated clinical benefits of GLP-1s include improved cardiometabolic risks, fewer major adverse cardiovascular events [23], decreased mortality in heart failure [[24], [25], [26], [27], [28]], and improvements in obstructive sleep apnea [12,29], prediabetes [30,31], chronic kidney disease [32], knee osteoarthritis [33], substance use disorders [34], and metabolic-associated steatotic liver disease [35]
of Tartus microbiology department discovered that ME-3 is capable of synthesizing glutathione
These medications, known as GLP-1 receptor agonists (GLP-1-RAs), offer promising therapeutic options for type 2 diabetes and obesity-related conditions, including cardiovascular disease (CVD) and non-alcoholic fatty liver disease (NAFLD) (6)